Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenobarbital Sodium Injection for Neonatal Seizures
NCT03602118Phase 3Withdrawn
- Sponsor
- PharPoint Research
- Start
- Nov 2019
- Primary completion
- May 2021
- Modality
- Allosteric Modulators
01
Overview
A Phase 3 trial of phenobarbital in neonatal seizures, sponsored by PharPoint Research. Planned start Nov 2019; status: withdrawn.
02
Drugs
phenobarbital
03
Conditions
neonatal seizures
Beyond the preview
Go deeper on NCT03602118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03602118.